Literature DB >> 11790141

Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.

Y H Sung1, J Shin, J Shin, W Lee.   

Abstract

Cyclin-dependent kinase (Cdk) inhibitor p21(Waf1/Cip1/Sdi1), a multifunctional protein, has a major role as tumor suppressor, mediating G1/S arrest through inhibition of Cdks. Recent biological studies of Cyclin D1/Cdk4 have proposed that p21 C-terminal domain (p21(CT)) plays a key role as a potent Cdk4 inhibitor. We report here solution structures of p21(CT) for both the free and Cdk4-bound forms using 2D transferred NOE spectroscopy and dynamical simulated annealing calculations. Even though p21(CT) peptide is very flexible in the free state, when it bound to Cdk4, the structure becomes well structured in the binding domain. Therefore we propose that p21(CT) experiences an extensive conformational change upon Cdk4 binding. This structural change of p21(CT) may suggest the molecular mechanism of p21 for specificity and inhibition mode to assemble different cyclin-Cdk complexes. Especially, our data suggests that the D(149)FYHSKRR(156) region of p21 is critical for Cdk4 binding, indicating that the major driving force for complex originates from hydrophobic interaction between p21 and Cdk4.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11790141     DOI: 10.1080/07391102.2001.10506751

Source DB:  PubMed          Journal:  J Biomol Struct Dyn        ISSN: 0739-1102


  2 in total

1.  Binding of calmodulin to the carboxy-terminal region of p21 induces nuclear accumulation via inhibition of protein kinase C-mediated phosphorylation of Ser153.

Authors:  Aina Rodríguez-Vilarrupla; Montserrat Jaumot; Neus Abella; Núria Canela; Sonia Brun; Carmen Díaz; Josep M Estanyol; Oriol Bachs; Neus Agell
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

2.  Residual structure within the disordered C-terminal segment of p21(Waf1/Cip1/Sdi1) and its implications for molecular recognition.

Authors:  Mi-Kyung Yoon; Veena Venkatachalam; Austin Huang; Byong-Seok Choi; Collin M Stultz; James J Chou
Journal:  Protein Sci       Date:  2009-02       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.